| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.12 | 0.06 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.06 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.078 | 0.06 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.069 | 0.06 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.064 | 0.06 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.06 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.067 | 0.07 |